Cellulitis
71
2
3
51
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
16 trials with published results (23%)
Research Maturity
51 completed trials (72% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.6%
4 terminated out of 71 trials
92.7%
+6.2% vs benchmark
25%
18 trials in Phase 3/4
31%
16 of 51 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 51 completed trials
Clinical Trials (71)
Clinical Efficacy of Stopping Oral Antibiotics When Symptoms Stop, Compared to 'Finishing the Course'
Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department
The Personalised Antibiotic Duration for Cellulitis (PAD-C) Study
Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
Intravenous Versus Oral Treatment of the Main Acute Infections
Study Assessing Impact of Dermatology Consultation for Patients Admitted With Cellulitis
High-dose Cephalexin for Cellulitis (HI-DOCC)
Perspectives on Antibiotics and Tracking Symptoms in Children
Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care
The Effect of Histopathologic Analysis and Tissue Cultures on Inpatient Management of Cellulitis and Pseudocellulitis
High-dose vs. Standard-dose Cephalexin for Cellulitis
RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction
Continuous Temperature Telemonitoring of Patients With COVID-19 and Other Infectious Diseases in Hospital at Home Using Viture
Utility of Thermal Imaging in Diagnosis of Cellulitis for Lower Extremity Complaints in the Emergency Department
Radiofrequency and Targeted Pressure Energy for Cellulite Reduction
Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital
Adjunctive Clindamycin for Cellulitis: C4C Trial.
Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)
Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)